CELESIA, BENEDETTO MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 4.757
AS - Asia 2.928
EU - Europa 2.761
SA - Sud America 503
AF - Africa 410
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.367
Nazione #
US - Stati Uniti d'America 4.607
SG - Singapore 1.447
RU - Federazione Russa 1.171
CN - Cina 704
IT - Italia 511
BR - Brasile 411
VN - Vietnam 304
IE - Irlanda 263
CI - Costa d'Avorio 192
DE - Germania 149
FR - Francia 144
KR - Corea 143
UA - Ucraina 140
IN - India 117
NG - Nigeria 111
CA - Canada 96
FI - Finlandia 94
GB - Regno Unito 72
SN - Senegal 43
SE - Svezia 41
HK - Hong Kong 38
PL - Polonia 37
MX - Messico 36
NL - Olanda 36
BD - Bangladesh 29
AR - Argentina 28
ES - Italia 23
ZA - Sudafrica 23
IQ - Iraq 19
ID - Indonesia 18
CO - Colombia 17
PK - Pakistan 17
JP - Giappone 15
EC - Ecuador 14
BE - Belgio 13
AT - Austria 12
TR - Turchia 11
VE - Venezuela 10
CH - Svizzera 9
CL - Cile 9
KE - Kenya 9
LB - Libano 9
BJ - Benin 8
GR - Grecia 8
PY - Paraguay 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
IR - Iran 7
SA - Arabia Saudita 7
TN - Tunisia 7
AU - Australia 6
JM - Giamaica 5
JO - Giordania 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
EG - Egitto 4
LT - Lituania 4
LV - Lettonia 4
NP - Nepal 4
DK - Danimarca 3
HR - Croazia 3
HU - Ungheria 3
MY - Malesia 3
OM - Oman 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
IL - Israele 2
KG - Kirghizistan 2
MD - Moldavia 2
PH - Filippine 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BS - Bahamas 1
CG - Congo 1
DM - Dominica 1
EU - Europa 1
GD - Grenada 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
ME - Montenegro 1
MN - Mongolia 1
MT - Malta 1
MW - Malawi 1
NR - Nauru 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
Totale 11.362
Città #
Dallas 903
Singapore 878
Santa Clara 645
Moscow 523
Chandler 378
San Jose 290
Ashburn 278
Dublin 261
Los Angeles 194
Abidjan 192
Beijing 166
Chicago 160
Jacksonville 150
Seoul 143
Hefei 138
Lauterbourg 124
Boardman 119
Catania 107
New York 103
Ho Chi Minh City 97
Munich 89
Abuja 84
Cambridge 64
Hanoi 64
Lawrence 64
Council Bluffs 61
Civitanova Marche 57
Buffalo 56
São Paulo 56
Andover 55
Helsinki 50
Kochi 48
Toronto 46
Dakar 42
Des Moines 35
Hong Kong 35
Nanjing 34
Orem 33
Warsaw 33
Lappeenranta 30
Rome 29
Houston 28
Montreal 27
Denver 25
Nanchang 25
Brooklyn 23
Wilmington 22
The Dalles 20
Atlanta 19
Chennai 19
Lagos 19
Amsterdam 18
Columbus 18
London 17
Milan 17
Phoenix 17
Boston 16
Mexico City 16
Stockholm 16
Da Nang 15
Johannesburg 15
Palermo 15
Poplar 15
San Mateo 15
Modica 14
Tokyo 14
Brussels 13
Parma 13
Rio de Janeiro 13
Grafing 12
Mumbai 12
Philadelphia 12
Rende 12
Shenyang 12
Bremen 11
Changsha 11
Dong Ket 11
Jiaxing 11
Milazzo 11
Tremestieri Etneo 11
Hebei 10
Ottawa 10
Nairobi 9
New Delhi 9
Saint Petersburg 9
Seattle 9
Cotonou 8
Madrid 8
Manchester 8
Miami 8
Port Harcourt 8
San Francisco 8
Tashkent 8
Tianjin 8
Turku 8
Biên Hòa 7
Brasília 7
Campinas 7
Charlotte 7
Haiphong 7
Totale 7.707
Nome #
"Diagnosis on the Dock" project: a proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model 334
A measles outbreak in Catania, Sicily: the importance of high vaccination coverage and early notification of cases for health and economic reasons 164
Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 159
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 154
Clinical characteristics and predictors of death among hospitalized patients infected with SARS‑CoV‑2 in Sicily, Italy: A retrospective observational study 154
[In Process Citation] 153
Long-Term Survivors in a Cohort of People Living with HIV Diagnosed between 1985 and 1994: Predictive Factors Associated with More than 25 Years of Survival 143
Atypical Presentation of PKDL due to Leishmania infantum in an HIV-Infected Patient with Relapsing Visceral Leishmaniasis 131
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 128
Post-infectious ST elevation myocardial infarction following a COVID-19 infection: A case report 126
Could we consider the intima-media thickness (c-IMT)> 1 mm as a risk factor for cardiovascular diseases in HIV plus subjects chronically treated with antiretrovirals? 123
Severe Neutropenia after Sarilumab Administration in Two COVID-19 Patients: Case Reports and Literature Review 122
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 120
Baseline CD4/CD8 T-cell Ratio Predicts Prompt Immune Restoration upon cART Initiation 118
HIV Infection Diagnosis in a Late Presenter Patient during a Severe Imported Falciparum Malaria: A Challenging 116
Analysis of impediments to the maintenance in care of people with HIV in Italy 115
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 115
Is it safe and cost saving to defer the CD4+ cell count monitoring in stable patients on ART with more than 350 or 500 cells/µL? 114
Long-term survivors in a cohort of HIV+ patients diagnosed between 1985 and 1992: predictive factors associated with more than 25 years of survival 114
Anxiety disorders and adherence to HAART 113
Rare case of Rhodococcus hoagii bacteremia in an HIV late‑presenter with NTM pulmonary disease: A case report and review of the literature 112
Influence of hepatitis G virus coinfection on the clinical course of chronic hepatitis C 112
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 111
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 109
Entecavir resistance in a patient with treatment‑naïve HBV: A case report 107
Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96-week retrospective study 106
HCV and HBV infection among multitransfused thalassemics from eastern Sicily 105
Preliminary investigation on intrafamilial spread of hepatitis C virus (HCV) 105
Hepatic echinococcosis: clinical and therapeutic aspects 104
High-flow nasal cannula oxygenation and tocilizumab administration in patients critically ill with COVID-19: A report of three cases and a literature review 103
Kidney disease in HIV-infected patients 102
Factors predicting tuberculosis reactivation in HIV-infected patients [PARAMETRI PREDITTIVI DI RIATTIVAZIONE TUBERCOLARE IN SOGGETTI CON INFEZIONE DA HIV] 102
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 101
Successful extracorporeal membrane oxygenation treatment in an acquired immune deficiency syndrome (AIDS) patient with acute respiratory distress syndrome (ARDS) complicating pneumocystis jirovecii pneumonia: A challenging case 101
Sarilumab administration in patients with severe COVID‑19: A report of four cases and a literature review 101
Predictive criteria of sustained virological response (more than 60 months) to Nevirapine-based antiretroviral treatment 99
Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review 99
The first report of HTLV-I infection associated with blood transfusion in a thalassemic patient from Sicily, Italy 98
Efficacy and safety of Atazanavir/Ritonavir therapy in a cohort of treatment-experienced patients 98
Trimethoprim-sulfamthoxazole associated severe hypoglicemia: a sulfnylurea like effect 98
Editorial-Coronavirus disease 2019 and people living with HIV: Clinical considerations 98
Ruolo del rapporto eterosessuale nella trasmissione dell’infezione HIV in un gruppo di tossicodipendenti della Sicilia Orientale. Necessità di modificare le strategie di prevenzione? 97
Cryptococcal meningitis in an HIV-1-infected person: relapses or IRIS? Case report and review of the literature 95
Pain crisis management in a patient with sickle cell disease during SARS‑CoV‑2 infection: A case report and literature review 95
Possible role of low dose dexamethasone administration in listeria monocytogenes meningoencephalitis: A case series 95
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 94
Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience 94
Laryngeal leishmaniasis in a HIV‑positive patient: A case report and review of the literature 93
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 93
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 93
Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders 90
Serum tumor necrosis factor in acute and fulminant hepatitis B 87
Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study 87
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 87
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 87
Hepatitis B virus infection and hepatocellular carcinoma in PLWH: epidemiology, pathogenesis and treatment 87
Sifilide ed HIV.Presentazione di tre casi clinici 87
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results a large multicentre observational prospective cohort (SCOLTA) 86
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 86
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 86
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 86
Test for CCR5 tropism and treatment with maraviroc in Sicily: an observational retrospective multicentre study 85
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 83
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 82
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 81
Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily 79
Microbial translocation in chronic liver diseases 77
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 77
Long-acting drugs: people's expectations and physicians' preparedness. Are we readying to manage it? An Italian survey 76
LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals 76
Ageing with HIV: a multidisciplinary review 76
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 75
Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV 74
Localizzazione osteoarticolare multipla in corso di sepsi da Staphylococcus aureus meticillino-resistente: Considerazioni clinico- terapeutiche [Multiple osteo-articular involvement due to methicillin-resistant Staphylococcus aureus septicaemia: clinical and therapeutic evaluation] 74
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 73
High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: A cross-sectional study 73
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 73
HCV and HIV infection among intravenous drug abusers in eastern Sicily 71
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort 71
Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review 70
Diagnosis, Treatment, and Prevention of HIV Infection among Detainees: A Review of the Literature 70
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 70
Sexual dysfunction in HIV plus subjects in eastern Sicily 69
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 69
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 68
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients 68
Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment 65
Factors associated with weight gain in people treated with dolutegravir 65
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 64
Archi-Prevaleat project. A national register of color-doppler ultrasonography of the epi-aortic vessels in patients living with HIV 64
Prevalenza e distribuzione dell’HHV-8 in differenti popolazioni con e senza infezione da HIV 63
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 63
Weight gain: A possible side effect of all antiretrovirals 63
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 63
Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review 62
Prevalence of HLA-B*5701 and access to genetic test in Sicily. A multicenter study 61
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 61
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial 61
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 60
New HIV diagnosis and linkage to care in two outpatient units in South Europe 60
Totale 9.527
Categoria #
all - tutte 37.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.377


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 0 0 0 0 0 0 24 52 18
2021/2022469 39 61 12 5 65 8 72 27 46 11 20 103
2022/20231.035 71 67 14 101 106 171 5 177 245 5 40 33
2023/2024496 28 63 21 32 22 135 5 35 4 22 79 50
2024/20252.656 25 287 110 104 567 334 92 86 236 276 293 246
2025/20266.255 382 380 1.081 530 1.065 1.344 641 159 276 397 0 0
Totale 11.591